Skip to main content

Tissue Engineering Market Set to Soar Past USD 32.45 Billion by 2030

The global Tissue Engineering market size is expected to reach USD 32.45 billion by 2030 and exhibit a CAGR of 10.7% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of chronic diseases and injuries requiring tissue replacements, advancements in regenerative medicine and biotechnology, rising demand for organ transplantation alternatives, a growing aging population with higher healthcare needs, and expanding research and development initiatives in tissue engineering are fueling the market’s growth.

Westford, USA, Feb. 02, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Tissue Engineering market, development of 3D bioprinting techniques for precise tissue fabrication, increased focus on stem cell therapies and gene editing for tissue regeneration, the emergence of bioactive scaffolds and biomaterials for enhanced tissue engineering, growing applications in orthopedics, cardiovascular, and dermatology, expanding research into tissue engineering for nerve and spinal cord repair, and the integration of artificial intelligence and machine learning for tissue modeling and drug testing are the trends that aid in the market’s growth.

Get sample copy of this report:

https://www.skyquestt.com/sample-request/tissue-engineering-market

Browse in-depth TOC on the “Tissue Engineering Market”

  • Pages – 157
  • Tables – 92
  • Figures – 74

Tissue engineering is an interdisciplinary field combining engineering and life sciences principles to develop biological substitutes that restore, maintain, or improve tissue function or a whole organ. It is a relatively new field, with the first tissue-engineered product approved by the FDA in 1996.

Prominent Players in Tissue Engineering Market

  • AbbVie (Allergan)
  • Acell
  • Athersys
  • BioTime
  • B. Braun
  • Cook Biotech
  • Integra LifeSciences
  • Medtronic
  • Organogenesis
  • Osiris Therapeutics (Smith & Nephew)
  • Stryker
  • Tissue Regenix
  • Zimmer Biomet
  • 3M
  • Advanced BioHealing
  • AlloSource
  • AxioBiologics
  • Cellumed
  • Cyfuse Biomedical
  • Humacyte
  • Organovo
  • Vericel

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/tissue-engineering-market

Biologically-Derived Materials Demand to Grow Substantially in the Forecast Period

Biologically-derived materials dominate the global online market as they are used in tissue engineering because they closely mimic the native tissue environment. These materials often promote cell adhesion, proliferation, and differentiation, making them valuable for regenerative medicine applications. They are commonly used to regenerate skin, cartilage, and soft tissues.

Orthopedics is the Leading Application Segment

In terms of application, orthopedics is the leading segment because the global population, especially in developed countries, is aging, leading to an increase in musculoskeletal disorders, joint injuries, and age-related degenerative conditions such as osteoarthritis. Orthopedic tissue engineering offered potential joint and bone regeneration solutions, making it a critical application.

North America is the leading Market Due to the Technological Advancements

Region-wise, North America is one of the largest growing markets with a huge emphasis on technological advancements. The region’s leadership was attributed to several factors, including a well-established healthcare system, significant investments in research and development, a large biotechnology and pharmaceutical industry, and a favorable regulatory environment for medical innovations. Leading research institutions and companies in the U.S. were actively involved in tissue engineering advancements.

A recent report thoroughly analyzes the major players operating within the Tissue Engineering market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavors to develop innovative solutions that cater to the ever-increasing demand for Tissue Engineering.

Key Developments in the Tissue Engineering Market

  • Researchers at Columbia University developed a technique to engineer functional human lungs using stem cells. The team used a combination of 3D bioprinting and tissue engineering to create a lung-like structure that could potentially be used for transplantation in the future.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/tissue-engineering-market

Key Questions Answered in Tissue Engineering Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Liver Health Supplements Market

Global Polymerase Chain Reaction (PCR) Market

Global Cyclodextrin Market

Global Induced Pluripotent Stem Cells Production Market

Global Muscle Relaxant Drugs Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.